Over the last few decades, there has been a development in the treatment of patient with kidney diseases. Once patients reach end-stage renal disease (ESRD), treatments are limited to kidney transplantation and dialysis. Recently, the end-stage renal disease (ESRD) has been redefined as chronic kidney disease (CKD), a progressive condition that culminates in ESRD. Nowadays, it is practically possible to treat CKD in its early stages or to slow, stop, or, reverse the progress of ESRD to prevent kidney failure.
This overall progress or development is called “ Quiet Revolution. ” This quiet revolution has presented an opportunity to improve patient outcomes, but at the same time it also poses challenges for both practitioners and policymakers. For instance, CKD represents a challenge in moving from dialysis, or kidney transplantation to a model that balances the relationship between…
